Kewalramani Reshma sold VRTX

February 16, 2024 · Form 4 insider transaction

Kewalramani Reshma sold 9,359 shares of Vertex Pharmaceuticals Incorporated at $424.01 per share, a transaction worth $3.97M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.